UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001454
Receipt number R000001761
Scientific Title Olmesartan or Pravastatine Trial on pre-metabolic syndrome
Date of disclosure of the study information 2010/04/01
Last modified on 2009/12/22 05:26:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Olmesartan or Pravastatine Trial on pre-metabolic syndrome

Acronym

Hokusetsu Trial

Scientific Title

Olmesartan or Pravastatine Trial on pre-metabolic syndrome

Scientific Title:Acronym

Hokusetsu Trial

Region

Japan


Condition

Condition

Hypertensive or Dyslipidemic patients

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine prospectively circumference of waist, postprandial metabolic parameters, adipocytokines, and oxidative stress markers in hypertensive or dyslipidemic patients with visceral fat accumulation, on Olmesartan or Pravastatine treatment for 3 months.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes of waist circumference, glucose-lipid metabolic parameters, and blood pressure, postprandial TBARS

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1)Hypertensive and/or diabetic male patients who understand the study procedures using explanatory notes and have given written informed consent to participate in the study
and
2)Patients have not yet received Olmesartan and Pravastatine.

Key exclusion criteria

1)Contraindications of Olmesartan
2)Contraindications of Pravastatine

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Iichiro Shimomura, Tohru Funahashi

Organization

Osaka University

Division name

Metabolic medicine

Zip code


Address

2-2 B5, Yamada-oka, Suita, Osaka, 565-0871, Japan

TEL

06-6879-3732

Email



Public contact

Name of contact person

1st name
Middle name
Last name Ken Kishida

Organization

Osaka University

Division name

Metabolic medicine

Zip code


Address


TEL


Homepage URL


Email

kkishida@imed2.med.osaka-u.ac.jp


Sponsor or person

Institute

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University

Institute

Department

Personal name



Funding Source

Organization

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 01 Day


Related information

URL releasing protocol

http://www.ncbi.nlm.nih.gov/pubmed/19850310?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1

Publication of results

Published


Result

URL related to results and publications

http://www.ncbi.nlm.nih.gov/pubmed/19850310?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 01 Month 29 Day

Date of IRB


Anticipated trial start date

2007 Year 04 Month 01 Day

Last follow-up date

2009 Year 04 Month 01 Day

Date of closure to data entry

2010 Year 03 Month 01 Day

Date trial data considered complete

2010 Year 03 Month 01 Day

Date analysis concluded

2010 Year 03 Month 01 Day


Other

Other related information

prospective study


Management information

Registered date

2008 Year 10 Month 23 Day

Last modified on

2009 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001761


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name